Hemagglutinins of Avian Influenza Viruses Are Proteolytically Activated by TMPRSS2 in Human and Murine Airway Cells.
Animals
Bronchi
/ cytology
Cell Line
Dogs
Female
HEK293 Cells
Hemagglutinin Glycoproteins, Influenza Virus
/ genetics
Hemagglutinins, Viral
/ genetics
Host-Pathogen Interactions
Humans
Influenza A Virus, H1N1 Subtype
/ physiology
Influenza A Virus, H3N2 Subtype
/ physiology
Influenza A virus
/ immunology
Lung
/ virology
Madin Darby Canine Kidney Cells
Male
Mice
Mice, Inbred C57BL
Mice, Knockout
Peptide Hydrolases
/ metabolism
Proteolysis
Respiratory Mucosa
/ metabolism
Serine Endopeptidases
/ metabolism
Virus Replication
TMPRSS2
avian influenza
hemagglutinin
influenza virus
monobasic cleavage site
morpholino oligomers
primary airway cells
virus-activating protease
Journal
Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724
Informations de publication
Date de publication:
27 09 2021
27 09 2021
Historique:
pubmed:
29
7
2021
medline:
29
3
2022
entrez:
28
7
2021
Statut:
ppublish
Résumé
Cleavage of the influenza A virus (IAV) hemagglutinin (HA) by host proteases is indispensable for virus replication. Most IAVs possess a monobasic HA cleavage site cleaved by trypsin-like proteases. Previously, the transmembrane protease TMPRSS2 was shown to be essential for proteolytic activation of IAV HA subtypes H1, H2, H7, and H10 in mice. In contrast, additional proteases are involved in activation of certain H3 IAVs, indicating that HAs with monobasic cleavage sites can differ in their sensitivity to host proteases. Here, we investigated the role of TMPRSS2 in proteolytic activation of avian HA subtypes H1 to H11 and H14 to H16 in human and mouse airway cell cultures. Using reassortant viruses carrying representative HAs, we analyzed HA cleavage and multicycle replication in (i) lung cells of TMPRSS2-deficient mice and (ii) Calu-3 cells and primary human bronchial cells subjected to morpholino oligomer-mediated knockdown of TMPRSS2 activity. TMPRSS2 was found to be crucial for activation of H1 to H11, H14, and H15 in airway cells of human and mouse. Only H9 with an R-S-S-R cleavage site and H16 were proteolytically activated in the absence of TMPRSS2 activity, albeit with reduced efficiency. Moreover, a TMPRSS2-orthologous protease from duck supported activation of H1 to H11, H15, and H16 in MDCK cells. Together, our data demonstrate that in human and murine respiratory cells, TMPRSS2 is the major activating protease of almost all IAV HA subtypes with monobasic cleavage sites. Furthermore, our results suggest that TMPRSS2 supports activation of IAV with a monobasic cleavage site in ducks.
Identifiants
pubmed: 34319155
doi: 10.1128/JVI.00906-21
pmc: PMC8475512
doi:
Substances chimiques
Hemagglutinin Glycoproteins, Influenza Virus
0
Hemagglutinins, Viral
0
hemagglutinin, human influenza A virus
0
trypsin-like serine protease
0
Peptide Hydrolases
EC 3.4.-
Serine Endopeptidases
EC 3.4.21.-
TMPRSS2 protein, human
EC 3.4.21.-
TMPRSS2 protein, mouse
EC 3.4.21.-
virus activating protease
EC 3.4.21.-
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0090621Subventions
Organisme : German Research Foundation
ID : SFB1021
Organisme : State of Hesse, LOEWE
ID : DRUID
Références
J Virol. 2014 May;88(9):4744-51
pubmed: 24522916
J Biol Chem. 2020 Aug 14;295(33):11388-11407
pubmed: 32303635
Nat Rev Genet. 2003 Jul;4(7):544-58
pubmed: 12838346
Curr Top Microbiol Immunol. 2014;385:93-116
pubmed: 25007844
Cell. 2015 Feb 12;160(4):631-643
pubmed: 25679759
J Virol. 2012 Dec;86(23):12861-70
pubmed: 22993148
Virology. 2020 Apr;543:43-53
pubmed: 32056846
Curr Top Microbiol Immunol. 2014;385:359-75
pubmed: 24990620
J Virol. 2014 Jan;88(1):282-91
pubmed: 24155384
J Virol. 2012 Oct;86(19):10579-86
pubmed: 22811538
Vaccine. 2007 Jul 26;25(30):5637-44
pubmed: 17126960
Virology. 1984 Dec;139(2):303-16
pubmed: 6516214
PLoS One. 2017 May 11;12(5):e0176597
pubmed: 28493964
Proc Natl Acad Sci U S A. 2000 May 23;97(11):6108-13
pubmed: 10801978
Lancet. 1999 Sep 11;354(9182):916-7
pubmed: 10489954
Am J Pathol. 2006 May;168(5):1513-25
pubmed: 16651618
J Virol. 2019 Oct 15;93(21):
pubmed: 31391268
Biochem Biophys Res Commun. 2014 Jul 25;450(2):1070-5
pubmed: 24978308
J Virol. 2013 Feb;87(3):1811-20
pubmed: 23192872
Clin Microbiol Rev. 2007 Apr;20(2):243-67
pubmed: 17428885
Cell. 1998 Oct 30;95(3):409-17
pubmed: 9814710
Arch Virol. 1995;140(2):341-8
pubmed: 7710359
Science. 2004 Mar 19;303(5665):1866-70
pubmed: 14764887
J Virol. 2006 Oct;80(19):9896-8
pubmed: 16973594
Nat Rev Microbiol. 2019 Jan;17(2):67-81
pubmed: 30487536
Biochim Biophys Acta. 2010 Dec;1798(12):2296-303
pubmed: 20170628
Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2579-84
pubmed: 22308331
Rev Sci Tech. 2009 Apr;28(1):161-73
pubmed: 19618624
J Virol. 2012 Jun;86(12):6537-45
pubmed: 22496216
BMC Genomics. 2010 Apr 01;11:220
pubmed: 20359326
Virology. 2007 May 10;361(2):384-90
pubmed: 17207830
Virology. 2018 Sep;522:37-45
pubmed: 30014856
J Virol. 2015 May;89(9):5154-8
pubmed: 25673722
Antimicrob Agents Chemother. 2016 Oct 21;60(11):6532-6539
pubmed: 27550352
J Virol. 2013 Apr;87(8):4237-51
pubmed: 23365447
Future Virol. 2014 May 1;9(5):513-524
pubmed: 25214882
Antiviral Res. 2011 Oct;92(1):27-36
pubmed: 21802447
Sci Rep. 2016 Jul 08;6:29430
pubmed: 27389476
J Virol. 2017 May 12;91(11):
pubmed: 28356532
PLoS One. 2015 Sep 11;10(9):e0137652
pubmed: 26360249
Virol J. 2020 Apr 22;17(1):56
pubmed: 32321537
PLoS One. 2012;7(4):e35876
pubmed: 22558251
J Virol. 2011 Feb;85(4):1554-62
pubmed: 21123387
Vaccine. 2009 Oct 23;27(45):6324-9
pubmed: 19840668
J Virol. 2021 Feb 24;95(6):
pubmed: 33361418
Cancer Res. 2015 Jul 15;75(14):2949-60
pubmed: 26018085
J Gen Virol. 2019 Jul;100(7):1073-1078
pubmed: 31099738
PLoS One. 2011;6(6):e20664
pubmed: 21697989
J Gen Virol. 2018 Sep;99(9):1187-1198
pubmed: 30084768
J Control Release. 2006 Dec 1;116(3):304-13
pubmed: 17097177
PLoS Pathog. 2013 Feb;9(2):e1003151
pubmed: 23459660
J Virol. 2014 May;88(10):5608-16
pubmed: 24600012
Mol Cell Biol. 2006 Feb;26(3):965-75
pubmed: 16428450
Antiviral Res. 1994 Feb;23(2):107-18
pubmed: 7511880
Viruses. 2019 Jul 05;11(7):
pubmed: 31284485
Emerg Infect Dis. 2012 May;18(5):814-6
pubmed: 22516302
Biol Chem. 2018 Sep 25;399(9):1053-1064
pubmed: 29883316
J Histochem Cytochem. 2003 Aug;51(8):1017-25
pubmed: 12871983
Curr Top Microbiol Immunol. 2014;385:3-34
pubmed: 25031010
PLoS Pathog. 2013;9(12):e1003774
pubmed: 24348248
Curr Top Microbiol Immunol. 2014;385:221-42
pubmed: 25015786
J Virol. 2019 Dec 12;94(1):
pubmed: 31597759
Life Sci Alliance. 2020 Jul 23;3(9):
pubmed: 32703818
Trends Microbiol. 2014 Apr;22(4):183-91
pubmed: 24582528